Found 7 results
Name | Type of Offering | Accepted Date |
---|---|---|
Enlaza Therapeutics, Inc.
|
D | 2021-03-24 21:40:22 |
Amount To Be Raised
$21,273,287
Associated Brokers / Dealers
N/A
CIK Number
0001852950
Filed Document
0001852950-21-000001
Exclusions or Exemptions
506b
Accepted Date
2021-03-24 21:40:22
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Enlaza Therapeutics, Inc.
|
D/A | 2022-11-22 16:20:17 |
Amount To Be Raised
$61,330,607
Associated Brokers / Dealers
N/A
CIK Number
0001852950
Filed Document
0001852950-22-000003
Exclusions or Exemptions
506b
Accepted Date
2022-11-22 16:20:17
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Enlaza Therapeutics, Inc.
|
D | 2022-10-13 17:04:03 |
Amount To Be Raised
$311,977
Associated Brokers / Dealers
N/A
CIK Number
0001852950
Filed Document
0001852950-22-000002
Exclusions or Exemptions
506b
Accepted Date
2022-10-13 17:04:03
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Enlaza Therapeutics, Inc.
|
D | 2021-08-13 13:44:55 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001852950
Filed Document
0001852950-21-000003
Exclusions or Exemptions
506b
Accepted Date
2021-08-13 13:44:55
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Enlaza Therapeutics, Inc.
|
D | 2022-10-13 16:34:48 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001852950
Filed Document
0001852950-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-10-13 16:34:48
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Enlaza Therapeutics, Inc.
|
D | 2021-06-28 15:07:18 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001852950
Filed Document
0001852950-21-000002
Exclusions or Exemptions
506b
Accepted Date
2021-06-28 15:07:18
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Enlaza Therapeutics, Inc.
|
D | 2024-08-09 16:40:08 |
Amount To Be Raised
$110,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001852950
Filed Document
0001852950-24-000001
Exclusions or Exemptions
506b
Accepted Date
2024-08-09 16:40:08
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|